Development of methods for detection of leukocyte antigens has made possible the classification of human leukocytes into different antigenic types, distinct from those of erythrocytes. To date several such antigen systems have been described (1) (2) (3) (4) . Studies on the distribution of some of these antigens in various blood cells have indicated that they are present in both granulocytic and nongranulocytic cells, as well as in platelets (5, 6) . It has been shown that these antigens are also present in certain nonhematopoietic tissues, such as placenta, kidney, and lung (5, 7) .
This study concerns a new leukocyte antigen, the first that appears to be specific for neutrophiles. In 2 unrelated families, this antigen was responsible for maternal immunization during pregnancy, and the subsequent transplacental transfer of the antibody appeared to be responsible for neonatal neutropenia.
Methods
Antibody sources. Test plasmas used in this study were obtained from 3 multiparous female donors. Maternal plasma DeR was obtained 7 years after the last pregnancy. The first, the third, and the fourth children of this donor had documented neonatal neutropenia and were subjects of a previous publication (8) . St plasma was obtained from the mother of a pair of dizygotic twins. The twins were the third and the fourth children of the family, and both had neonatal neutropenia (9) . The third plasma, containing a monospecific antibody * Submitted for publication November 26, 1965; accepted August 1, 1966. Supported by U. S. Public Health Service grant HE 10036-01. Presented (10) , was also obtained from a multiparous female, none of whose children ever presented any evidence of neutropenia. This antibody had previously been shown to detect an antigen common to leukocytes, platelets, and several solid tissues. Of these donors only Mrs. Ke had received a tranfusion-1 U of blood 6 years before the present study, 30 years after her last pregnancy.
Blood was anticoagulated with 1/100th vol of 10% disodium ethylenediaminetetraacetate (EDTA) , and cellpoor plasma was collected after centrifugation at 1,350 g for 30 minutes. Plasma specimens were stored in 1-ml aliquots at -200 C.
Cell preparations for agglutination reaction. Leukocyte suspensions were prepared by a method in which hexadimethrine bromide (Polybrene) is used for sedimenting red cells in blood samples anticoagulated by EDTA (11) . The leukocyte-rich supernatants were separated from healthy normal blood donors, and the leukocyte counts were adjusted to about 4,000 per mm' by dilution with autologous cell-poor plasma. Leukocytes with a high proportion of eosinophiles were obtained from patients with various parasitic infestations or the Loffler syndrome. Preparations with a high proportion of lymphocytes were obtained from healthy children under the age of 8.
Test system. Leukocyte antigen-antibody reactions were studied., by a previously described agglutination method (10) , in which serial twofold dilutions of all the test plasmas -were prepared in 0.1-ml vol, with isotonic saline as the diluent. To each dilution, 0.05 ml of leukocyte suspension was added. The results were read microscopically after 5 and 18 hours of incubation at 370 C.
The strength of the agglutination reaction was graded as previously described (10) , and the antibody titer was determined as the highest dilution of the test plasma that produced agglutination.
At the end of the incubation period, the incubation mixtures with high lymphocytes or eosinophiles were placed on microscope slides, dried, and subjected to Wright and Giemsa staining for microscopic examination (12) .
Cell preparations for absorption. Blood cells were prepared from normal healthy donors as described by Green and Solomon (13) . In this method leukocyteplatelet-rich plasma is obtained after dextran sedimentation of red cells. The cells in the supernatant are then sedimented by contrifugation in the narrow part of an "oil bottle," yielding distinct layers of the various 1741 cell types. Each layer may thus be separately aspirated and resuspended in the donor's own cell-poor plasma. Relatively pure platelet, mononuclear, and granulocyte suspensions can thus be obtained. Platelet preparations were virtually free from other contaminating cells. Separated mononuclear cells, which usually had 5 to 10% (by volume) platelet contamination, were centrifuged at 350 g for 15 minutes. This centrifugation, which allowed sedimentation of mononuclear cells while keeping the platelets in suspension, was usually repeated once or twice until the packed cells contained no more than 2%o (by volume) platelets. This was measured by applying the microcapillary method used for the "leukocrit" determination (10) whereby leukocytes and platelets are packed into two macroscopically distinct layers. Thus, it was possible to determine the size of each layer. Differential counts were performed on stained smears of concentrated cell preparations. Mononuclear preparations, which were contaminated by neutrophiles in excess of 12%, as determined by differential counts on 300 cells, were not used. Monocytes and large lymphocytes constituted about one-third of the mononuclear cells, the remaining being small lymphocytes. In the granulocyte layer, red cells represented about 2%o of the packed cell volume, mononuclear cell contamination did not exceed 5%,o and platelets were virtually absent.
Although eosinophiles could not be prepared with the same degree of purity as other cells, it was possible to obtain concentrated preparations by use of blood from two nonleukemic patients with eosinophilia. One patient had LUffler's pneumonia; the other had chronic eosinophilia of undetermined origin. In these patients the leukocyte counts were between 20,000 and 40,000 mm3, 80%o of which were eosinophiles. The techniques used for cell separation were those described above for preparation of leukocytes, and the final suspensions contained about 80% eosinophiles.
Solid tissues were processed as follows: Placenta was obtained from the delivery room; liver, kidney, and lung were from autopsies performed not later than 4 hours after death. Tissues were cut into pieces approximately 10 X 10 X 2 mm and were rinsed repeatedly in isotonic saline until the wash solution was grossly clear. The fragments were passed through a 100-mesh stainless steel screen, and the separated cells were suspended and washed three times in 12 ml of normal plasma obtained from male donors who had not received transfusions. For each washing, the cell suspensions were centrifuged at 350 g for 15 minutes. Leukocyte typing of all tissue donors was determined ante-mortem; with placenta, the agglutination reactions of both maternal and cord leukocytes were ascertained.
Method for absorption and elution. In preliminary experiments-, the separated blood cells were adjusted to a "leukocrit" or "thrombocrit" of 15%o, a concentration that had been satisfactory in the study of Ke antibody (10) . It soon became evident that with this antigen concentration, DeR antibody was only partially absorbed; for complete absorption, it was necessary to use packed cells. In each experiment, volumes of packed blood or tissue cells, from 0.2 to 1 ml, were resuspended in 3 vol of undiluted plasma containing the antibody, and the mixtures were incubated at 37°C for 30 minutes. The absorbed plasmas were then separated by 15 minutes of centrifugation at 1,350 g.
For antibody elution, the packed cells obtained after absorption experiments were resuspended and washed five times in 12 ml of isotonic saline. The washed, packed cells were finally resuspended in twice their volume of saline. The cell suspensions were then heated at 560 C for 10 minutes and centrifuged at 1,350 g for 10 minutes in a clinical centrifuge kept at 56°C in a heated box. The absorbed plasmas and the eluates were stored at -20°C until used.
DEAE cellulose column chromatography was performed on immune plasmas as previously described (10).
Results
As determined by DEAE cellulose column chromatography, DeR antibody was mainly in the plasma fractions eluted by 0.02 M phosphate buffer pH 6.3 and corresponding to yG-globulins. The fraction eluted by 1 M NaCl, which contained yM-globulins, had little activity. These findings are illustrated in 
Properties of St antibody
The titer of St antibody ranged from 1 :2 to 1: 16 with leukocytes obtained from various donors. As described for DeR plasma, St plasma was also subjected to DEAE cellulose column chromatography, and antibody activity was mainly found in -yG-globulin fractions. Distribution of the antigen in various blood cells and body tissues was also studied. As shown in Figure 5 bodies eluted from each of these cell preparations agglutinated the leukocytes of both fathers.
These data suggest that similar to DeR, St antibody reacts only with neutrophiles and that both detect the same antigen.
Variation in the antibody titers found with different leukocyte donors raised the possibility that the observed phenomenon might represent a dose effect. Family members of donors whose leukocytes gave negative reactions, or those which strongly reacted with one of the antibodies, were studied. The leukocyte preparations were simultaneously tested with DeR and St plasmas. The results are shown in Figure 6 . It was found that both antibodies invariably showed a parallel reactivity with each donor, but the titer with St antibody was 2 to 3 tubes less than that obtained for DeR.
DeR and other leukocyte antigens
During the Second International conference and workshop on tissue typing held in Leiden, Holland, in August 1965, DeR plasma and 76 other antileukocyte antisera were tested against a panel of 40 leukocyte donors. The antisera used in this study were provided from different laboratories and were presumed to be monospecific. These antisera identified most of the previously known leukocyte antigens. To evaluate possible relationships between the antigens identified by these sera, we compared the reaction patterns produced by each with the aid of a computer. DeR plasma revealed a positive correlation to only one antiserum, B/14.3 This antibody had been produced by active immunization in a hematologically normal subject, by repeated injections of 3 (16) . By a cytotoxicity test, however, B/14 contained a mixture of antibodies, different from the agglutinin, with prevalent anti4a activity (17) .
Further agglutination studies performed in this laboratory revealed similar specificity for DeR and B/14 antisera with 20 additional leukocyte donors. The only difference was in the much higher titer obtained with B/14.3 The distribution of antigen detected by B/14 was also studied, and as shown in Figure 7 , it was found that the antibody was absorbed only by blood neutrophiles; no antibody absorption was achieved by red cells, platelets, mononuclear cells, or kidney, lung, or liver cells. These observations were reproduced by the use of platelets from 3 different sources and tissues of 2 different donors. It was also found that blood lymphocytes and eosinophiles did not participate in neutrophile agglutination produced by B/14 antibody. Mattiuz and Ceppellini have recently confirmed these findings; they have shown that lymphocyte suspensions obtained from BU+ donors did not absorb EDTA agglutinins (17) .
Discussion
The data presented above indicate the identification of an antibody directed against an antigen that is unique to neutrophilic leukocytes. A single antigen was evidently detected, as illustrated by two different test systems: Absorption studies with DeR+ leukocytes caused complete removal of DeR antibody by each of a panel of leukocyte donors; plasma so absorbed failed to react with leukocytes from numerous unrelated DeR+ subjects. Eluted antibody from each individual leukocyte preparation reacted with all the leukocyte samples with which the unabsorbed plasma reacted, and the previously negative sam- ples remained negative. These findings are in contrast to those obtained with plasmas from multitransfused patients, which contained multiple antibodies against several different leukocyte antigens. When these "complex" antibodies were completely absorbed with leukocytes from a single donor, residual antibody activity remained that was active against cells from most other unrelated donors (10) . The finding of concordant reactions produced by both DeR and St plasmas in 100 different donors indicates that both plasmas detect the same antigen (p <0.0001 by the x2 method). This interpretation is further supported by DeR and St family studies, in which the two maternal leukocyte preparations were nonreactive and the paternal cells strongly reacted with both antibodies. Furthermore, when the two antisera were absorbed with the paternal cells of one family, they both became nonreactive with the paternal cells of the other family, and the antibody eluted from these absorbing cells had identical specificity.
The antigen demonstrated by DeR and St antibodies appears to be identical to the antigen detected by the leukocyte agglutinin present in B/14 antiserum, an antibody experimentally produced by Ceppellini and his associates. This neutrophile-specific isoantibody produced by an immunization route other than transplacental is a helpful adjunct to the present observations. The DeR antigen system may be composed of two or more alleles. Since 56%o of the population reacts with the antibody, DeR and its allele would have gene frequencies of 0.56 and 0.44, respectively, were the alleles limited to two. Twelve per cent of the population would be DeR homozygous and 44%o heterozygous. Confirmation of these values awaits discovery of the allelic antigen. The results of the family studies suggest a genetic pattern, and although our effort to find an antibody that may detect the postulated allele has thus far been unsuccessful, the family data obtained are consistent with the hypothesis that the strength of the reaction is related to the antigen dose. Leukocytes of presumed heterozygotes were less reactive than cells of presumed homozygotes. This phenomenon, however, may also be due to augmentation by an unrelated gene. Although observation of a dose effect from leukocyte antigens has not been previously reported, this phenomenon is well known to occur with the red cells (18, 19 (14, 17) , the failure of DeR antibody to exert cytotoxicity on lymphocytes is an observation in agreement with the conclusion that DeR antigen is not present on lymphocytes. Distribution of leukocyte antigens in granulocytes and lymphocytes has been studied (5, 15, 20) . According to these reports, suggestive evidence indicates that granulocytes and lymphocytes may have antigenic differences. With the discovery of specific leukocyte groups, it has been shown that antigens of groups 4 and 5 are present on granulocytes, lymphocytes, platelets, and several tissues including kidney, placenta, skin, lung, and spleen (1, 5 ). An additional system of leukocyte antigens, designated LA, has also been found in lymphocytes and platelets (6) . Shulman, Marder, Aledort, and Hiller have described a lymphocyte-specific antigen (21) . Thus, DeR antigen is unique to date in its specific localization to neutrophiles. The present study demonstrates that within a group of closely related cells such as eosinophiles and neutrophiles, antigenic differences may exist. This finding does not imply different origins for these cells, but may rather be related to specialized cell functions.
The observation that DeR antigen is confined to neutrophiles corresponds to laboratory findings in the affected children with neonatal neutropenia, who showed transient but specific absence of neutrophiles in their peripheral blood and bone marrows, with preservation of other blood elements (8, 9, 22) . Identification of the same antigen, responsible for the development of maternal antibodies and the subsequent occurrence of neonatal neutropenia in two unrelated families, supports the concept that a similar immune mechanism was involved in both cases. It was also shown that both antibodies were primarily 7 S globulins, proteins capable of crossing the placenta. These findings may offer an explanation for the rarity of this entity: Significant neutropenia occurred when the involved antigen was limited to neutrophiles. In contrast, antibodies to leukocyte antigens with wide blood and tissue distribution do not produce leukopenia. If maternal antibodies to the latter type of antigens cross the placenta, they may be absorbed by various tissues to such a degree that their effects on neutrophiles are negligible. Thus, investigators (22) (23) (24) who failed to find neonatal neutropenia in babies born to mothers who had leukocyte antibodies may have been working with antibodies having a broad spectrum of cell reactivity.
The incidence of maternal immunization against various leukocyte antigens may be related to their tissue distribution. Mothers are more likely to become immunized against ubiquitous antigens when antigenic stimuli arise from fetal cells other than leukocytes, and even placental cells. On the other hand, for immunization against fetal-specific neutrophile antigens, the antigenic stimulus can derive only from fetal neutrophiles. In view of these considerations, many maternal leukocyte antibodies may be eliminated as potential sources of neonatal neutropenia.
Whether specific cell antigens are significant in homograft rejection is unknown, but their presence suggests that this potential source of incompatibility should be explored. Summary A leukocyte antigen is described that is unique to blood neutrophiles and appears to be involved in the pathogenesis of neonatal neutropenia. The antigen was identified by a leukocyte agglutinin found in plasmas of 2 unrelated mothers, each of whom had several newborns with isoimmune neonatal neutropenia. The antibodies were demonstrated to be primarily yG-globulins. Evidence was obtained to indicate that antibodies of both mothers identified the same antigen. Cross absorption and antibody elution studies demonstrated that a single antigenic determinant with a gene frequency of 0.56 was involved. Antibody absorption and elution were achieved only by neutrophiles. The antigen was not found on red cells, platelets, mononuclear cells, eosinophiles, placenta, or lung, liver, or kidney cells. This antigen distribution correlates with the selective neutropenia observed in the affected newborns.
We suggest that this specific localization of the antigen is essential for the occurrence of neonatal neutropenia and that leukocyte antibodies directed against widely distributed antigens are not likely to affect the neutrophiles of the newborn.
